Extensive, shallow mineralisation beyond the existing resource puts even more low-cost gold on the table for the heap leach ...
Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results